Publications by authors named "Laird A Miers"

Claim this Profile
P
Pharmacokinetic characterization in xenografted mice of a series of first-generation mimics for HLA-DR antibody, Lym-1, as carrier molecules to image and treat lymphoma.
Gerald L DeNardo, Arutselvan Natarajan, Saphon Hok, Julie Perkins, Monique Cosman, Laird A Miers

J Nucl Med· August 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thermal dosimetry predictive of efficacy of 111In-ChL6 nanoparticle AMF--induced thermoablative therapy for human breast cancer in mice.
Sally J DeNardo, Gerald L DeNardo, Arutselvan Natarajan, Laird A Miers, Allan R Foreman

J Nucl Med· March 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of tumor targeting bioprobes ((111)In-chimeric L6 monoclonal antibody nanoparticles) for alternating magnetic field cancer therapy.
Sally J DeNardo, Gerald L DeNardo, Laird A Miers, Arutselvan Natarajan, Alan R Foreman

Clin Cancer Res· October 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical evaluation of cathepsin-degradable peptide linkers for radioimmunoconjugates.
Gerald L DeNardo, Sally J DeNardo, James J Peterson, Laird A Miers, Kit S Lam

Clin Cancer Res· September 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-CD22 ligand-blocking antibody HB22.7 has independent lymphomacidal properties and augments the efficacy of 90Y-DOTA-peptide-Lym-1 in lymphoma xenografts.
Joseph M Tuscano, Robert T O'Donnell, Laird A Miers, Linda A Kroger, David L Kukis

Blood· May 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cilengitide targeting of alpha(v)beta(3) integrin receptor synergizes with radioimmunotherapy to increase efficacy and apoptosis in breast cancer xenografts.
Patricia A Burke, Sally J DeNardo, Laird A Miers, Kathleen R Lamborn, Siegfried Matzku

Cancer Res· August 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combined modality radioimmunotherapy. Promise and peril.
Patricia A Burke, Sally J DeNardo, Laird A Miers, David L Kukis, Gerald L DeNardo

Cancer· February 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combined modality radioimmunotherapy for human prostate cancer xenografts with taxanes and 90yttrium-DOTA-peptide-ChL6.
Robert T O'Donnell, Sally J DeNardo, Laird A Miers, Kathleen R Lamborn, David L Kukis

Prostate· January 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis